Biotech & Pharma.T.A, Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A,

BIB 74.47

-2.1%

Nov 13 4:00 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Jibacoa who wrote (2084)	2/4/2008 10:44:34 AM
From: Jibacoa	Read Replies (1) of 3722

NSTK Has been trying to stay above the $2.30 level in spite of its larger losses & lower revenues. bigcharts.marketwatch.com On Jan 8 it announced that the Patent Office has allowed its application entitled "Phage Displayed Trp Cage Ligands" that relates to a method for identifying peptides which can bind to specific cell types.(Its primarily focus remains on the intranasal delivery of compounds ranging from small molecules to peptides and proteins.) NSTK has a pretty good institutional following & the insiders hold > 5% finance.yahoo.com The short ratio increased 20% in the last month & is around 6x its ADV. With its losses the stock will still face problems ahead. If it could get back to the $5 level it would be a good % gain from present levels. But don't expect for it to retest the Nov 2 H at $15 this Yr.<g> bigcharts.marketwatch.com Bernard

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next